NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAWS OR REGULATIONSVita 34 AG launches voluntary public exchange offer for PBKM shares Vita 34 published prospectus for volunt [ … ]

Vita 34 again achieves double-digit growth in revenues and earnings in the first half of the year - Revenues increase by 13.7 percent to EUR 10.8 million - Adjusted EBITDA rises disproportionately by 20.3 percent to EUR 3.2 million - Operating cash flow and liquidity reflect positive business performanceLeipzig, 31 August 2021 - Vita 34 AG (ISIN:  [ … ]

Andreas Schafhirt appointed as new Chief Financial Officer of Vita 34 AG - Interim assumption of position until end of April 2022 - Previous CFO Falk Neukirch resigned from the company Leipzig, 16 August 2021 - The Supervisory Board of Vita 34 AG (ISIN: DE000A0BL849; WKN: A0BL84), one of Europe's largest cell banks, has appointed Andreas Schafhi [ … ]

Vita 34 publishes figures for the first quarter of 2021 - Revenues in Q1 2021 at EUR 5.4 million after EUR 4.6 million in Q1 2020 - Adjusted EBITDA at EUR 1.7 million after EUR 1.1 million in Q1 2020 - Investments in marketing and sales reflected in increased demand in DACH region Leipzig, 31 May 2021 - Vita 34 AG (ISIN: DE000A0BL849; WKN: A0BL84 [ … ]

Vita 34 AG signs Business Combination Agreement with Polski Bank Komórek Macierzystych S.A. - Vita 34 AG ("Vita 34"), one of the largest cell banks in Europe, plans to combine its business with Polski Bank Komórek Macierzystych S.A. ("PBKM"), which leads FamiCord Group, Europe's largest stem cell bank. On 31 May the companies signed a Business Com [ … ]

Vita 34 continues to grow in 2020 in core markets after good year-end business Revenues slightly up on previous year at EUR 20.1 million after good fourth quarter Core markets in DACH show disproportionately strong gains and develop increasingly positively EBITDA reduces to EUR 5.3 million due to costs of takeover bid Leipzig, 30 March 2021 - V [ … ]

Vita 34 manages crisis environment well with a strong third quarter Revenues after nine months of EUR 15.0 million almost at previous year's level EBITDA margin of 29.1 percent despite increased marketing expenses, close to the target of 30 percent Increased demand for new PUR price model leads to steady increase in recurring sales Leipzig, 12 N [ … ]

Business development of Vita 34 gains significant momentum again in the second quarter Revenues up again significantly compared with the previous quarter EBITDA margin increases to 29.3 percent in the second quarter Good cash flow development allows cash and cash equivalents to rise significantly to EUR 9.9 million Leipzig, 27 August 2020 - The  [ … ]